Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 479

1.

Nanoparticle-Conjugate TLR7/8 Agonist Localized Immunotherapy Provokes Safe Antitumoral Responses.

Nuhn L, De Koker S, Van Lint S, Zhong Z, Catani JP, Combes F, Deswarte K, Li Y, Lambrecht BN, Lienenklaus S, Sanders NN, David SA, Tavernier J, De Geest BG.

Adv Mater. 2018 Oct 1:e1803397. doi: 10.1002/adma.201803397. [Epub ahead of print]

PMID:
30276880
2.

Modifying Rap1-signalling by targeting Pde6δ is neuroprotective in models of Alzheimer's disease.

Dumbacher M, Van Dooren T, Princen K, De Witte K, Farinelli M, Lievens S, Tavernier J, Dehaen W, Wera S, Winderickx J, Allasia S, Kilonda A, Spieser S, Marchand A, Chaltin P, Hoogenraad CC, Griffioen G.

Mol Neurodegener. 2018 Sep 26;13(1):50. doi: 10.1186/s13024-018-0283-3.

3.

The autophagy receptor SQSTM1/p62 mediates anti-inflammatory actions of the selective NR3C1/glucocorticoid receptor modulator compound A (CpdA) in macrophages.

Mylka V, Deckers J, Ratman D, De Cauwer L, Thommis J, De Rycke R, Impens F, Libert C, Tavernier J, Vanden Berghe W, Gevaert K, De Bosscher K.

Autophagy. 2018;14(12):2049-2064. doi: 10.1080/15548627.2018.1495681. Epub 2018 Sep 14.

PMID:
30215534
4.

Treatment with mRNA coding for the necroptosis mediator MLKL induces antitumor immunity directed against neo-epitopes.

Van Hoecke L, Van Lint S, Roose K, Van Parys A, Vandenabeele P, Grooten J, Tavernier J, De Koker S, Saelens X.

Nat Commun. 2018 Aug 24;9(1):3417. doi: 10.1038/s41467-018-05979-8.

5.

Discovering cellular protein-protein interactions: Technological strategies and opportunities.

Titeca K, Lemmens I, Tavernier J, Eyckerman S.

Mass Spectrom Rev. 2018 Jun 29. doi: 10.1002/mas.21574. [Epub ahead of print] Review.

PMID:
29957823
6.

The intracellular domain of the leptin receptor prevents mitochondrial depolarization and mitophagy.

Wauman J, Tavernier J.

Biochim Biophys Acta Mol Cell Res. 2018 Sep;1865(9):1312-1325. doi: 10.1016/j.bbamcr.2018.06.009. Epub 2018 Jun 19.

PMID:
29932990
7.

KISS: A Mammalian Two-Hybrid Method for In Situ Analysis of Protein-Protein Interactions.

Masschaele D, Gerlo S, Lemmens I, Lievens S, Tavernier J.

Methods Mol Biol. 2018;1794:269-278. doi: 10.1007/978-1-4939-7871-7_18.

PMID:
29855964
8.

Effect of combining glucocorticoids with Compound A on glucocorticoid receptor responsiveness in lymphoid malignancies.

Clarisse D, Van Wesemael K, Tavernier J, Offner F, Beck IM, De Bosscher K.

PLoS One. 2018 May 8;13(5):e0197000. doi: 10.1371/journal.pone.0197000. eCollection 2018.

9.

High-Confidence Interactome for RNF41 Built on Multiple Orthogonal Assays.

Masschaele D, Wauman J, Vandemoortele G, De Sutter D, De Ceuninck L, Eyckerman S, Tavernier J.

J Proteome Res. 2018 Apr 6;17(4):1348-1360. doi: 10.1021/acs.jproteome.7b00704. Epub 2018 Mar 26.

PMID:
29560723
10.

Germline gain-of-function myeloid differentiation primary response gene-88 (MYD88) mutation in a child with severe arthritis.

Sikora KA, Bennett JR, Vyncke L, Deng Z, Tsai WL, Pauwels E, Layh-Schmitt G, Brundidge A, Navid F, Zaal KJM, Hanson E, Gadina M, Staudt LM, Griffin TA, Tavernier J, Peelman F, Colbert RA.

J Allergy Clin Immunol. 2018 May;141(5):1943-1947.e9. doi: 10.1016/j.jaci.2018.01.027. Epub 2018 Feb 7. No abstract available.

PMID:
29427642
11.

A safe and highly efficient tumor-targeted type I interferon immunotherapy depends on the tumor microenvironment.

Cauwels A, Van Lint S, Garcin G, Bultinck J, Paul F, Gerlo S, Van der Heyden J, Bordat Y, Catteeuw D, De Cauwer L, Rogge E, Verhee A, Uzé G, Tavernier J.

Oncoimmunology. 2017 Nov 27;7(3):e1398876. doi: 10.1080/2162402X.2017.1398876. eCollection 2018.

PMID:
29399401
12.

Coregulator profiling of the glucocorticoid receptor in lymphoid malignancies.

Clarisse D, Thommis J, Van Wesemael K, Houtman R, Ratman D, Tavernier J, Offner F, Beck I, De Bosscher K.

Oncotarget. 2017 Nov 30;8(65):109675-109691. doi: 10.18632/oncotarget.22764. eCollection 2017 Dec 12.

13.

Co-Activation of Glucocorticoid Receptor and Peroxisome Proliferator-Activated Receptor-γ in Murine Skin Prevents Worsening of Atopic March.

Deckers J, Bougarne N, Mylka V, Desmet S, Luypaert A, Devos M, Tanghe G, Van Moorleghem J, Vanheerswynghels M, De Cauwer L, Thommis J, Vuylsteke M, Tavernier J, Lambrecht BN, Hammad H, De Bosscher K.

J Invest Dermatol. 2018 Jun;138(6):1360-1370. doi: 10.1016/j.jid.2017.12.023. Epub 2017 Dec 27.

PMID:
29288652
14.

Delivering Type I Interferon to Dendritic Cells Empowers Tumor Eradication and Immune Combination Treatments.

Cauwels A, Van Lint S, Paul F, Garcin G, De Koker S, Van Parys A, Wueest T, Gerlo S, Van der Heyden J, Bordat Y, Catteeuw D, Rogge E, Verhee A, Vandekerckhove B, Kley N, Uzé G, Tavernier J.

Cancer Res. 2018 Jan 15;78(2):463-474. doi: 10.1158/0008-5472.CAN-17-1980. Epub 2017 Nov 29.

PMID:
29187401
15.

TYK2-induced phosphorylation of Y640 suppresses STAT3 transcriptional activity.

Mori R, Wauman J, Icardi L, Van der Heyden J, De Cauwer L, Peelman F, De Bosscher K, Tavernier J.

Sci Rep. 2017 Nov 21;7(1):15919. doi: 10.1038/s41598-017-15912-6.

16.

Theranostic Radiolabeled Anti-CD20 sdAb for Targeted Radionuclide Therapy of Non-Hodgkin Lymphoma.

Krasniqi A, D'Huyvetter M, Xavier C, Van der Jeught K, Muyldermans S, Van Der Heyden J, Lahoutte T, Tavernier J, Devoogdt N.

Mol Cancer Ther. 2017 Dec;16(12):2828-2839. doi: 10.1158/1535-7163.MCT-17-0554. Epub 2017 Oct 20.

PMID:
29054987
17.

The online Tabloid Proteome: an annotated database of protein associations.

Gupta S, Turan D, Tavernier J, Martens L.

Nucleic Acids Res. 2018 Jan 4;46(D1):D581-D585. doi: 10.1093/nar/gkx930.

18.

The Prader-Willi syndrome proteins MAGEL2 and necdin regulate leptin receptor cell surface abundance through ubiquitination pathways.

Wijesuriya TM, De Ceuninck L, Masschaele D, Sanderson MR, Carias KV, Tavernier J, Wevrick R.

Hum Mol Genet. 2017 Nov 1;26(21):4215-4230. doi: 10.1093/hmg/ddx311.

PMID:
28973533
19.

Glucocorticoid Receptor-mediated transactivation is hampered by Striatin-3, a novel interaction partner of the receptor.

Petta I, Bougarne N, Vandewalle J, Dejager L, Vandevyver S, Ballegeer M, Desmet S, Thommis J, De Cauwer L, Lievens S, Libert C, Tavernier J, De Bosscher K.

Sci Rep. 2017 Aug 21;7(1):8941. doi: 10.1038/s41598-017-09246-6.

20.

Compound A influences gene regulation of the Dexamethasone-activated glucocorticoid receptor by alternative cofactor recruitment.

Desmet SJ, Bougarne N, Van Moortel L, De Cauwer L, Thommis J, Vuylsteke M, Ratman D, Houtman R, Tavernier J, De Bosscher K.

Sci Rep. 2017 Aug 14;7(1):8063. doi: 10.1038/s41598-017-07941-y.

Supplemental Content

Loading ...
Support Center